Table 1.

Therapeutic regimens of patients.

Chemotherapy	Number (percentage)
Total	223
Single agent	22 (9.8)
Platinum-based combined drugs	201 (90.2)
Docetaxel or Paclitaxel	58 (26.0)
Vinorelbine	55 (24.7)
Gemcitabine	57 (25.6)
Pemetrexed	31 (13.9)